| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.19B | 7.95B | 7.45B | 7.35B | 6.80B |
| Gross Profit | 415.00M | 1.70B | 1.55B | 1.34B | 1.49B |
| EBITDA | 681.00M | 557.96M | 395.24M | 3.80M | 383.08M |
| Net Income | 117.00M | 32.83M | -52.83M | -308.87M | 21.78M |
Balance Sheet | |||||
| Total Assets | 10.51B | 9.56B | 8.71B | 8.71B | 9.08B |
| Cash, Cash Equivalents and Short-Term Investments | 513.00M | 684.46M | 757.27M | 564.58M | 1.24B |
| Total Debt | 2.29B | 2.33B | 2.91B | 3.21B | 3.56B |
| Total Liabilities | 9.52B | 8.72B | 8.28B | 8.12B | 8.25B |
| Stockholders Equity | 997.00M | 849.46M | 433.12M | 585.50M | 818.58M |
Cash Flow | |||||
| Free Cash Flow | 203.62M | 180.80M | 378.40M | -352.60M | 504.56M |
| Operating Cash Flow | 596.28M | 444.73M | 636.73M | -57.72M | 862.37M |
| Investing Cash Flow | -666.71M | -240.47M | -104.95M | -225.01M | -535.22M |
| Financing Cash Flow | -94.84M | -272.38M | -331.26M | -389.52M | -377.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €36.69B | 20.00 | 22.15% | 0.93% | 15.41% | 70.46% | |
74 Outperform | €5.15B | 16.35 | 42.37% | 2.73% | 12.34% | 23.90% | |
72 Outperform | €30.50B | 23.17 | 12.10% | 1.05% | 9.80% | 13.78% | |
66 Neutral | €9.09B | 15.58 | 13.05% | 6.99% | 6.52% | 1.86% | |
56 Neutral | €4.27B | 46.08 | 14.30% | ― | 12.19% | 177.33% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | €2.53B | 14.02 | 15.02% | 2.32% | 14.59% | 23.80% |